Global Health Progress

Dr. Paul Antony, medical director of Global Health Progress, made the following statement in response to the Clinton Foundation’s plan to make malaria drugs more broadly available to the developing world.

Persons with disabilities have the right to access healthcare and rehabilitation on an equal basis as others.

Time: 10-11:30 am
Event Location: Global Health Council
Neglected tropical diseases have afflicted humanity since time immemorial and, in their long histories, have acquired notoriety as disabling and deforming diseases. Today, those most affected are the poorest populations – often living in remote, rural areas, urban slums or in conflict zones.
Approximately 1 billion [...]

Giving schoolchildren in rural Kenya regular doses of malaria medicine, even if they weren’t obviously sick, seemed to improve their attention span in school, a study has found.

Time: 10:00 AM
Event Location: National Press Club, Zenger Room
Tommy G. Thompson, former Secretary of the US Department of Health and Human Services, will discuss his new role in the global health arena, the fight against neglected tropical diseases, and the importance of “global medical diplomacy.”
The leaders [...]

July 13 – August 8, 2008
Bellagio, Italy

eHealth is defined as the use of information and communications technology to improve the performance of health systems and represents a promising frontier. Members of the international community – donors, governments, industry, researchers and civil society are engaged in this effort to raise the profile of eHealth, form [...]

Working Together to Make a Difference
The research and development (R&D) of innovative new drugs and vaccines is a critical component of improving health care and combating epidemics in developing countries. For some widespread and life-threatening diseases such as malaria, no vaccines exist, while current treatments for diseases such as tuberculosis are becoming less effective due [...]

Fighting disease in the developing world requires multi-sector solutions that address the complex challenges of delivering effective care. At least one-third of the world’s population lacks regular access to basic health care due to inadequacies in infrastructure and delivery systems, a lack of effective public health systems and insufficient resources. In several African countries, nearly [...]

Research-based biopharmaceutical companies are active partners in some of the largest and boldest health initiatives to explore new and effective ways of increasing access to health care in the developing world.
These companies are committed to fighting devastating diseases such as AIDS, tuberculosis (TB) and malaria through the research and development (R&D) of new drugs, diagnostics [...]

The worldwide pharmaceutical industry is joining the World Health Organization (WHO) and the Drugs for Neglected Diseases initiative (DNDi) in calling on the G-8 to recognize the importance of neglected diseases as a global health threat and a major strain on the economic viability and educational development of communities worldwide.”